rt-PA plus Eptifibatide versus rt-PA Alone in Acute Ischemic Stroke: A Propensity Score Matched Post Hoc Analysis

BACKGROUND AND PURPOSE: The CLEAR-ER trial demonstrated safety of rt-PA plus eptifibatide in acute ischemic stroke (AIS). CLEAR-ER randomized AIS patients (5:1) to 0.6mg/kg rt-PA plus eptifibatide versus standard rt-PA (0.9mg/kg). IMS III randomized AIS patients to rt-PA plus endovascular therapy ve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stroke
Main Authors: Adeoye, Opeolu, Sucharew, Heidi, Khoury, Jane, Tomsick, Thomas, Khatri, Pooja, Palesch, Yuko, Schmit, Pamela A., Pancioli, Arthur M., Broderick, Joseph P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4308493/
https://ncbi.nlm.nih.gov/pubmed/25523054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.114.006743
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados